Loading clinical trials...
Loading clinical trials...
Adult patients with ESBL-producing Gram negative infections are randomized to receive ertapenem or meropenem/imipenem. Clinical and microbiological responses between both groups are compared.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Mahidol University
NCT01722916 · Drug Safety
NCT06889376 · Drug Safety
NCT01669824 · Aspirin, Drug Safety, and more
NCT04785027 · Traditional Chinese Medicine, Drug Effect, and more
NCT01367873 · Drug Safety
Siriraj Hospital
Bangkok, Bangkok
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions